Home / Markets / Capital Market News / Godavari Drugs standalone net profit declines 36.20% in the June 2025 quarter

Godavari Drugs standalone net profit declines 36.20% in the June 2025 quarter

Last Updated : Aug 14 2025 | 9:20 AM IST

Sales decline 26.08% to Rs 23.81 crore

Net profit of Godavari Drugs declined 36.20% to Rs 1.04 crore in the quarter ended June 2025 as against Rs 1.63 crore during the previous quarter ended June 2024. Sales declined 26.08% to Rs 23.81 crore in the quarter ended June 2025 as against Rs 32.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales23.8132.21 -26 OPM %12.1410.03 -PBDT1.902.56 -26 PBT1.302.01 -35 NP1.041.63 -36

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Sandu Pharmaceuticals standalone net profit rises 29.41% in the June 2025 quarter

Parker Agrochem Exports reports standalone net loss of Rs 0.04 crore in the June 2025 quarter

Premier Capital Services reports standalone net loss of Rs 0.17 crore in the June 2025 quarter

Fedders Electric & Engineering standalone net profit declines 18.47% in the June 2025 quarter

South Asian Enterprises reports standalone net loss of Rs 0.06 crore in the June 2025 quarter

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 14 2025 | 7:35 AM IST